Trial Profile
A Phase I/II Study Of OSI-774 In Combination With Oxaliplatin And 5-Fluourouracil In Patients With Metastatic Colorectal Carcinoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Nov 2007 New trial record.